CY1849A - Antitumor antibiotic dedarcidin - Google Patents

Antitumor antibiotic dedarcidin

Info

Publication number
CY1849A
CY1849A CY184996A CY184996A CY1849A CY 1849 A CY1849 A CY 1849A CY 184996 A CY184996 A CY 184996A CY 184996 A CY184996 A CY 184996A CY 1849 A CY1849 A CY 1849A
Authority
CY
Cyprus
Prior art keywords
dedarcidin
antitumor antibiotic
kedarcidin
protein
antibiotic
Prior art date
Application number
CY184996A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY1849A publication Critical patent/CY1849A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY184996A 1988-04-12 1996-03-08 Antitumor antibiotic dedarcidin CY1849A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18051988A 1988-04-12 1988-04-12
US07/323,001 US5001112A (en) 1988-04-12 1989-03-17 Antitumor antibiotic kedarcidin

Publications (1)

Publication Number Publication Date
CY1849A true CY1849A (en) 1996-03-08

Family

ID=26876396

Family Applications (1)

Application Number Title Priority Date Filing Date
CY184996A CY1849A (en) 1988-04-12 1996-03-08 Antitumor antibiotic dedarcidin

Country Status (24)

Country Link
US (1) US5001112A (da)
EP (1) EP0337430B1 (da)
JP (1) JP2850132B2 (da)
KR (1) KR970010137B1 (da)
CN (1) CN1034589C (da)
AT (1) ATE101653T1 (da)
AU (1) AU623641B2 (da)
CA (1) CA1338262C (da)
CY (1) CY1849A (da)
DE (1) DE68913063T2 (da)
DK (1) DK174751B1 (da)
ES (1) ES2061760T3 (da)
FI (1) FI93969C (da)
HK (1) HK83195A (da)
HU (1) HU201119B (da)
IE (1) IE62912B1 (da)
IL (1) IL89896A0 (da)
MY (1) MY105842A (da)
NO (1) NO174474C (da)
NZ (1) NZ228672A (da)
PL (1) PL161004B1 (da)
PT (1) PT90252B (da)
SG (1) SG30654G (da)
YU (1) YU73989A (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143906A (en) * 1991-09-26 1992-09-01 Bristol-Myers Squibb Company Kedarcidin antitumor chromophore and pharmaceutical composition containing same
CA2414570A1 (en) * 2002-01-24 2003-04-03 Ecopia Biosciences Inc. Method, system, and knowledge repository for identifying a secondary metabolite from a microorganism
PT2349520T (pt) * 2008-10-27 2016-08-16 Glaxosmithkline Biologicals Sa Método de purificação para hidrato de carbono de estreptococos grupo a

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS519837B2 (da) * 1974-03-29 1976-03-30
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS6017206B2 (ja) * 1977-03-24 1985-05-01 浩 前田 ネオカルチノスタチン誘導体の製造法
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
JPS57206693A (en) * 1981-06-10 1982-12-18 Ajinomoto Co Inc Protein an-7d
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物

Also Published As

Publication number Publication date
PT90252A (pt) 1989-11-10
CN1037735A (zh) 1989-12-06
HUT50880A (en) 1990-03-28
DK173589A (da) 1989-10-13
NO891462D0 (no) 1989-04-10
PL161004B1 (pl) 1993-05-31
FI891710L (fi) 1989-10-13
NZ228672A (en) 1990-07-26
JP2850132B2 (ja) 1999-01-27
NO891462L (no) 1989-10-13
DE68913063D1 (de) 1994-03-24
PL278782A1 (en) 1989-12-27
HU201119B (en) 1990-09-28
EP0337430A2 (en) 1989-10-18
US5001112A (en) 1991-03-19
PT90252B (pt) 1994-07-29
JPH01317396A (ja) 1989-12-22
AU3272889A (en) 1989-10-19
KR900016469A (ko) 1990-11-13
FI93969B (fi) 1995-03-15
FI93969C (fi) 1995-06-26
ATE101653T1 (de) 1994-03-15
EP0337430A3 (en) 1991-07-24
DE68913063T2 (de) 1994-06-09
IE891157L (en) 1989-10-12
EP0337430B1 (en) 1994-02-16
DK173589D0 (da) 1989-04-11
YU73989A (en) 1991-04-30
MY105842A (en) 1995-01-30
ES2061760T3 (es) 1994-12-16
HK83195A (en) 1995-06-01
SG30654G (en) 1995-09-01
KR970010137B1 (ko) 1997-06-21
NO174474C (no) 1998-06-09
NO174474B (no) 1994-01-31
DK174751B1 (da) 2003-10-20
CN1034589C (zh) 1997-04-16
IL89896A0 (en) 1989-12-15
CA1338262C (en) 1996-04-23
IE62912B1 (en) 1995-03-08
AU623641B2 (en) 1992-05-21
FI891710A0 (fi) 1989-04-11

Similar Documents

Publication Publication Date Title
AU569776B2 (en) Atrial natriuretic factors
CA2054268A1 (en) Nutritional composition
AU3444989A (en) Biosynthetic osteogenic proteins and osteogenic devices containing them
AU5245186A (en) Oxidation resistant mutant proteins
NZ503850A (en) April - a novel protein with growth effects
AU1422492A (en) Pea protein hydrolyzate, method for production thereof and use thereof
SG143926A1 (en) Cd-i pointer device with 8 direction, 1 pixel/ update
AU3457889A (en) Tracheobronchodilator
AU570572B2 (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
AU8188087A (en) Variants of hirudin, their use and their preparation
YU73989A (en) Cedarcidin
EP0358217A3 (en) Image reading apparatus
GR3006045T3 (da)
AU3810389A (en) Process for extracting and purifying epidermin
WO1990000179A3 (fr) Nouvelles proteins, adn les codant et leur usage
AU8379191A (en) Cassette for the expression of an endothiapepsin precursor in cryphonectria parasitica
AU7296487A (en) Replacing timing chains on vehicles
EP0322717A3 (en) Dactylocycline a and dactylocycline b
CS331286A1 (en) 2 (terc. amino) 11 (4 methylpiperazino) 10,11dihydrodibenzo(b,f)thiepiny a jejich jantarany